Hashimoto, Y.; Yamasaki, R.; Ko, S.; Matsuo, E.; Kobayakawa, Y.; Masaki, K.; Matsuse, D.; Isobe, N.
Connexin 30 Deficiency Ameliorates Disease Progression at the Early Phase in a Mouse Model of Amyotrophic Lateral Sclerosis by Suppressing Glial Inflammation. Int. J. Mol. Sci. 2022, 23, 16046.
https://doi.org/10.3390/ijms232416046
AMA Style
Hashimoto Y, Yamasaki R, Ko S, Matsuo E, Kobayakawa Y, Masaki K, Matsuse D, Isobe N.
Connexin 30 Deficiency Ameliorates Disease Progression at the Early Phase in a Mouse Model of Amyotrophic Lateral Sclerosis by Suppressing Glial Inflammation. International Journal of Molecular Sciences. 2022; 23(24):16046.
https://doi.org/10.3390/ijms232416046
Chicago/Turabian Style
Hashimoto, Yu, Ryo Yamasaki, Senri Ko, Eriko Matsuo, Yuko Kobayakawa, Katsuhisa Masaki, Dai Matsuse, and Noriko Isobe.
2022. "Connexin 30 Deficiency Ameliorates Disease Progression at the Early Phase in a Mouse Model of Amyotrophic Lateral Sclerosis by Suppressing Glial Inflammation" International Journal of Molecular Sciences 23, no. 24: 16046.
https://doi.org/10.3390/ijms232416046
APA Style
Hashimoto, Y., Yamasaki, R., Ko, S., Matsuo, E., Kobayakawa, Y., Masaki, K., Matsuse, D., & Isobe, N.
(2022). Connexin 30 Deficiency Ameliorates Disease Progression at the Early Phase in a Mouse Model of Amyotrophic Lateral Sclerosis by Suppressing Glial Inflammation. International Journal of Molecular Sciences, 23(24), 16046.
https://doi.org/10.3390/ijms232416046